: Global medical cannabis now accounts for 81% of total revenue and 95% of adjusted gross profit , with medical margins holding steady at 69% . Market Sentiment & Ratings
Should You Buy, Hold or Sell ACB Stock Post Q3 Earnings Release? buy acb stock
Professional outlooks on ACB are mixed, balancing its medical leadership against broader sector risks. : Global medical cannabis now accounts for 81%
As of April 28, 2026, Aurora Cannabis (ACB) is trading at , reflecting a 19.12% decline year-to-date . The company is currently executing a strategic shift to prioritize high-margin global medical cannabis markets over lower-margin consumer segments. Aurora Cannabis Inc (ACB) -19.12% since Jan 2, 2026 Closed: 4:00 PM • Disclaimer After hours: 7:30 PM Apr 27, 2026 Mkt cap$271.06M CAD 52-wk high6.67 P/E ratio- 52-wk low3.07 Div yield- Financial Performance & Health As of April 28, 2026, Aurora Cannabis (ACB)